维持性血液透析对终末期肾病合并HBV感染者病毒载量的影响

张会芳; 李用国

doi:10.3969/j.issn.1001-5256.2017.07.033

维持性血液透析对终末期肾病合并HBV感染者病毒载量的影响

DOI: 10.3969/j.issn.1001-5256.2017.07.033

哈尔滨医科大学附属第一医院感染科

详细信息

中图分类号: R512.62;R692.5
计量
- 文章访问数: 1164
- HTML全文浏览量: 23
- PDF下载量: 351
- 被引次数: 0
出版历程
- 收稿日期: 2017-01-12
- 出版日期: 2017-07-20

Influence of maintained hemodialysis on viral load in patients with end-stage renal disease with HBV infection

Department of Infectious Diseases, The First Affiliated Hospital of Harbin Medical University

摘要

摘要: 终末期肾病合并HBV感染的血液透析患者,其HBV DNA载量相对较低且稳定。有研究认为,血液透析对HBV DNA载量有一定影响,可以降低HBV DNA载量,但是具体机制尚不清楚。可能与以下因素有关:HBV DNA通过透析膜进入到透析液中,HBV DNA吸附在透析膜上,部分病毒颗粒被破坏以及血液透析过程中产生具有抗病毒特性的物质。目前对于维持性血液透析HBV感染者的影响机制尚无统一结论。综述了维持性血液透析对终末期肾病合并HBV感染者的影响因素及其最新进展。
- 血液透析滤过 /
- 终末期肾病 /
- 肝炎病毒,乙型 /
- 病毒载量 /
- 综述
Abstract: In the patients with end-stage renal disease (ESRD) with hepatitis B virus (HBV) infection who underwent hemodialysis, the viral load of HBV DNA is relatively low and stable.For this phenomenon, some studies suggest that hemodialysis can reduce the HBV DNA load.The mechanism, which remains unclear, may be as follows:when HBV DNA enters the dialysate through the dialysis membrane, it was adsorbed onto the dialysis membrane;some virus particles were destroyed, and antiviral substances were produced in the course of hemodialysis.At present, there is no consensus on the mechanism responsible for the influence of maintained hemodialysis on the viral load of HBV DNA.This article reviews the factors involved in the influence of maintained hemodialysis on the viral load in ESRD patients with HBV infection and the recent progress.
- hemodiafiltration /
- end-stage renal disease /
- hepatitis B virus /
- viral load /
- review

HTML全文

参考文献(34)

[1]XIANG F, ZHU J, CAO X, et al.Lymphocyte depletion and subset alteration correlate to renal function in chronic kidney disease patients[J].Ren Fail, 2015, 130 (9) :1-8.

[2]Chinese Society of Hepatology, Chinese Medical Association.Expert consensus on antiviral therapy for chronic hepatitis B with renal injury or high risk of renal injury[J].J Clin Hepatol, 2016, 32 (12) :2242-2247. (in Chinese) 中华医学会肝病学分会.伴有肾脏损伤及其高危风险的慢性乙型肝炎患者抗病毒治疗专家共识[J].临床肝胆病杂志, 2016, 32 (12) :2242-2247.

[3]WANG X, ZHOU Y, ZHU N, et al.The deposition of Notch1 in hepatitis B virus-associated nephropathy and its role in hepatitis Bvirus X proteininduced epithelial-mesenchymaltransdifferentiation and immunity disorder in renal tubular epithelial cells[J].J Viral Hepat, 2014, 21 (10) :734-743.

[4] SHEN QH.Chinese patients with uremia tend to have a younger age[N].Health News, 2011-11-15. (in Chinese) 申琼鹤.中国尿毒症患者年轻化趋势明显提高[N].健康报, 2011-11-15.

[5]ZHANG YZ, SU W, SHANG YQ, et al.A clinical study of decrease in hepatitis B surface antibody titer in patients on maintenance hemodialysis[J].Occupat Health, 2012, 28 (4) :503-504. (in Chinese) 张岩郅, 苏伟, 尚有全, 等.维持性血液透析患者乙肝表面抗体滴度衰减的临床观察[J].职业与健康, 2012, 28 (4) :503-504.

[6]LIU Q, YAO L, LIU XD, et al.Analysis of virus hepatitis infection in maintenance hemodialysis patients[J].Chin J Blood Purificat, 2012, 11 (8) :417-420. (in Chinese) 刘强, 姚丽, 刘晓丹, 等.维持性血液透析患者病毒性肝炎感染分析[J].中国血液净化, 2012, 11 (8) :417-420.

[7]KOHLER H.Hepatitis B immunization in dialysis patients-is it worthwhile?[J].Nephrol Dial Transplant, 1994, 9 (12) :1719-1720.

[8]MOUTINHO RS, PEREZ RM, MEDIAN-PESTANA JO, et al.Low HBV DNA levels in end-stage renal disease patients with HBe Agnegative chronic hepatitis B[J].J Med Virol, 2006, 78 (10) :1284-1288.

[9]WANG HL, PEGN HQ, LIN WP, et al.Clinical investigation and analysis in maintenance hemodialysis patients with HBV and HCVinfection[J].Chin J Blood Purificat, 2012, 11 (3) :168-170. (in Chinese) 汪虹伶, 彭洪泉, 林婉萍, 等.维持性血液透析患者乙型肝炎和丙型肝炎病毒感染临床调查分析[J].中国血液净化, 2012, 11 (3) :168-170.

[10]PATEL C, MONGAETAL D, ALEXANDER M, et al.Spontaneous clearance of hepatitis B surface antigenemia after long-term hemodialysis[J].Semin Dial, 2014, 27 (1) :57-59.

[11]FABRIZI F, MESSA P, MARTIN P.Hepatitis B virus infection and the dialysis patient[J].Semin Dial, 2008, 21 (5) :440-446.

[12]WONG PN, FUNG TT, MAK K, et al.Hepatitis B virus infection in dialysis patients[J].J Gastroenterol Hepatol, 2005, 20 (11) :1641-1651.

[13]CARVALHO-FILHO RJ, FELDNER AC, SILVA AE, et al.Management of hepatitis C in patients with chronic kidney disease[J].World JGastroenterol, 2015, 21 (2) :408-422.

[14]TSENG GY, LIN HJ, FANG CT, et al.Hemodialysis reduces the viral load in uremic patients with chronic hepatitis B infection[J].Ren Fail, 2008, 30 (10) :1000-1005.

[15]FURUSYO N, HAYASHI J, ARIYAMA I, et al.Maintenance hemodialysis decreases serum hepatitis C virus (HCV) RNA levels in hemodialysis patients with chronic HCV infection[J].Am J Gastroenterol, 2000, 95 (2) :490-496.

[16]KROES AC, van BOMMEL EF, NIESTERS HG, et al.Hepatitis Bviral DNA detectable in dialysate[J].Nephron, 1994, 67 (3) :369.

[17]EISEI N, AKIHIDE N, AKIRA O, et al.Hepatitis C virus in blood and dialysate in hemodialysis[J].Am J Kidney Dis, 2001, 37 (1) :38-42.

[18]GARCIA-VALDECASASJ, GARCIA F, BERNAL MC, et al.Can HCV-RNA pass through dialysis (HD) membranes?[J].JAm So Nephro, 1998 (abstr) , 19:209A.

[19]CARAMELO C, NAVAS S, ALBEROLA ML, et al.Evidence against transmission of hepatitis C virus through hemodialysis ultrafiltrate and peritoneal fluid[J].Nephron, 1994, 66 (4) :470-473.

[20]FABRIZI F, MESSA P, MARTIN P.Impact of hemodialysis therapy on hepatitis C virus infection:a deeper insight[J].Int J Artif Organs, 2009, 32 (1) :1-11.

[21]BOROS P, MILLER CM.Hepatocyte growth factor:a multifunctional cytokine[J].Lancet, 1995, 345 (8945) :293-295.

[22]CHEN EL, CHEN Z.Research advances in hepatocyte growth factor and liver diseases[J].J Nantong Univ (Med Sci) , 2013, 33 (4) :310-314. (in Chinese) 陈二林, 陈钟.肝细胞生长因子与肝脏疾病的研究进展[J].南通大学学报 (医学版) , 2013, 33 (4) :310-314.

[23]LIU R, WU S, CAO G, et al.Transfection of human hepatocyte growth factor gene inhibits advancing pulmonary arterial hypertension induced by shunt flow in a rabbit model[J].Transplant Proc, 2013, 45 (2) :705-712.

[24]SALA V, CREPALDI T.Novel therapy for myocardial infarction:can HGF/Met be beneficial?[J].Cell Mol Life Sci, 2011, 68 (10) :1703-1717.

[25]CHEN AP, ZENG ZY, YANG SS, et al.Combination transplantation of bone marrow mesenchymal stem cells and hepatocyte growth factor gene in the treatment of chronic ischemic heart disease in pigs[J].Chin J Clin Thoracic Cardiovascular Surg, 2012, 19 (3) :286-292. (in Chinese) 陈安平, 曾志勇, 杨胜生, 等.肝细胞生长因子及骨髓间充质干细胞联合移植治疗慢性缺血性心脏病的实验研究[J].中国胸心血管外科临床杂志, 2012, 19 (3) :286-292.

[26]XIA GY, JIANG ZZ, DONG L, et al.Experimental study of ultrasound microbubble-mediated HGF gene transfer on liver fibrosis in rats[J].Chin J Ultrasonogr, 2011, 20 (8) :707-710. (in Chinese) 夏国园, 江珍珍, 董梁, 等.超声作用下微泡携肝细胞生长因子治疗大鼠肝纤维化的实验研究[J].中华超声影像学杂志, 2011, 20 (8) :707-710.

[27]BILEZIKCI B, DEMIRHAN B, OZDERMIR N, et al.Expression of hepatocyte growth factor in chronic hepatitis:effect of hemodialysis[J].Renal Failure, 2006, 28 (7) :557-560.

[28]RAMPINO T, LIBETTA C, SIMONE WD, et al.Hemodialysis prevents liver disease caused by hepatitis C virus:role of hepatocyte growth factor release[J].Kidney Int, 2000, 56 (6) :2286-2291.

[29]CHRISTIDOU F, BAMICHAS G, GALAKTIDOU G, et al.Elevated hepatocyte growth factor levels at the beginning of high-flux hemodialysis are due to heparin administration[J].Renal Failure, 2009, 30 (9) :861-864.

[30]RAMPINO T, LIBETTA C, SIMONE WD, et al.Hemodialysis stimulates hepatocyte growth factor release[J].Kidney Int, 1998, 53 (5) :1382-1388.

[31]Chinese Society of Hepatology and Chinese Society of Infectious Diseases Chinese, Medical Association.The guide line of prevention and treatment for chronic hepatitis B:a 2015 update[J].J Clin Hepatol, 2015, 31 (12) :1941-1960. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2015年更新) [J].临床肝胆病杂志, 2015, 31 (12) :1941-1960.

[32]BADALAMENTI S, CATANIA A, LUNGHI G, et al.Changes in viremia and circulating interferon during hemodialysis in hepatitis Cvirus-positive patients:only coincidental phenomena?[J].Am JKidney Dis, 2003, 42 (1) :143-150.

[33]FABRIZI F, LUNGHI G, ALONGI G, et al.Kinetics of hepatitis Bvirus load during haemodialysis sessions andα-interferon:a prospective study[J].Kidney Blood Press Res, 2013, 37 (4-5) :286-294.

[34]KWON E, CHO JH, JANG HM, et al.Differential effect of viral hepatitis infection on mortality among korean maintenance dialysis patients:a prospective multicenter cohort study[J].PLo S One, 2015, 10 (8) :e0135476.

施引文献

资源附件(0)

访问统计